Cow’s milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity - 07/08/11
Supported by a grant from DBV Technologies, Paris, France. |
|
Disclosure of potential conflict of interest: C. Dupont invests in and receives honoraria and research support from DBV Technologies. P.-H. Benhamou invests in and receives honoraria and research support from DBV Technologies. The rest of the authors have declared that they have no conflict of interest. |
Vol 125 - N° 5
P. 1165-1167 - Maggio 2010 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?